The power package. Your talent. Our tools.

Solitaire™ X revascularization device

Together with your expertise and our devices,
we can power the future of stroke treatment.​

Navigate tortuous anatomy with confidence.

First pass performance

The parametric design of the Solitaire™ X device offers reliable retrieval and optimal reperfusion rates.1,2*

Optimal engagement

Self-expanding design provides multiple planes of contact for dynamic clot integration.3,4*
 

Accurate visualization

Real-time visualization of the distinctive, evenly spaced platinum markers enables accurate alignment and feedback during the procedure with a 3-D perspective.5*

Simple, effective, and clinically proven — the stent retriever that built the stroke community’s confidence in mechanical thrombectomy.1, 2, 6
 

Optimize outcomes by minimizing the number of passes.7-9

A large real-world patient cohort demonstrated a first pass effect (FPE) rate of 40.5% and a modified FPE (mFPE) rate of 58.9% across patients treated with the Solitaire™ device.10 †

  

Solitaire™ X device

See how the Solitiare™ X device can help you achieve the clinical outcomes you expect.

Clinical evidence

Read robust data about the most-published stent retriever.1

AIS portfolio

Discover our stroke products, from stent retrievers to aspiration systems.

*

Based on bench testing results. Bench testing may not be representative of actual clinical performance.

FPE defined as mTICI2c/3; modified FPE defined as mTICI 2b-3.

1

Medtronic Data on File. Solitaire Literature Review Aug2022. Includes Solitaire FR, Solitaire 2, Solitaire Platinum, Solitaire X.

2

Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731.  

3

TR-NV13807A, D00419703B.

4

TR-NV13807A, TR-NV15666AA, D00419703A, D00324045A. 

5

TR-NV12692A. 

6

Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020–3035.

7

García-Tornel Á, Requena M, Rubiera M, et. al. When to stop (published correction appears in Stroke. 2020 Jun;51(6):e118). Stroke. 2019;50(7):1781–1788.

8

Zaidat OO, Castonguay AC, Linfante I, et al. First pass effect: A new measure for stroke thrombectomy devices. Stroke. 2018;49(3):660–666. 

9

Flottmann F, Leischner H, Broocks G, et al. Recanalization rate per retrieval attempt in mechanical thrombectomy for acute ischemic stroke. Stroke. 2018;49(10):2523–2525. 

10

Jadhav AP, Desai SM, Zaidat OO, et al. First pass effect with neurothrombectomy for acute ischemic stroke: Analysis of the systematic evaluation of patients treated with stroke devices for acute ischemic stroke registry. Stroke. 2022;53(2):e30–e32. 

11

TR-NV15436C, D00272862C, D00344794B, TR-NV15519A, TR-NV15666A.